Which S&P500 stocks are the most active on Thursday?
By Mill Chart
Last update: Apr 18, 2024
Thursday's session: most active stock in the S&P500 index
Today's most active stocks
| Ticker | Change | Comment |
|---|---|---|
| TSLA | -3.63% | TESLA INC's (NASDAQ:TSLA) traded a high volume of 70.25M shares. With a decline of 3.63%, NASDAQ:TSLA is facing a downward movement in its share price today. |
| AMD | 0.18% | The trading volume for ADVANCED MICRO DEVICES (NASDAQ:AMD) has reached 37.59M shares in today's session, reflecting significant market participation. Leading to a price increase of 0.18%. A press release (AMD to Report Fiscal First Quarter 2024 Financial Results) was released two days ago. |
| NVDA | 0.74% | 33.96M shares of NVIDIA CORP (NASDAQ:NVDA) have been traded so far today. Shares are rising by 0.74% today, reflecting bullish market sentiment and upward price movement. |
| UAL | 4.53% | So far 26.13M shares of UNITED AIRLINES HOLDINGS INC (NASDAQ:UAL) have traded in today's session. The share price increased by 4.53%. A press release (United Airlines Soars on Earnings Beat) was released yesterday. |
| AAPL | -0.76% | The trading volume for APPLE INC (NASDAQ:AAPL) has reached 24.63M shares in today's session, reflecting significant market participation. Investors witnessed a notable decrease in share prices, with a loss of 0.76%. A press release (Way2Fix Revolutionizes Tech Support with On-Site Home and Office Service) was released two days ago. |
| AAL | 1.19% | 23.93M shares of AMERICAN AIRLINES GROUP INC (NASDAQ:AAL) exchanged hands today. The share price increased by 1.19% today, indicating positive momentum in the market. |
| BAC | 1.29% | So far 22.41M shares of BANK OF AMERICA CORP (NYSE:BAC) have traded in today's session. The share price increased by 1.29%. Yesterday the company had a press release: Commercial Banks Could Be Back in Play, Led by Bank of America. |
| PFE | -0.55% | The trading volume for PFIZER INC (NYSE:PFE) has been quite high, with 22.33M shares exchanged. Shares are falling by 0.55%. |
| F | -0.17% | The trading volume for FORD MOTOR CO (NYSE:F) has reached 21.88M shares in today's session, reflecting significant market participation. Leading to a price decrease of 0.17%. |
| INTC | -2.09% | 19.37M shares of INTEL CORP (NASDAQ:INTC) exchanged hands today. The market is witnessing a downward movement, with a 2.09% decrease in share prices. Yesterday the company had a press release: Big CIO Show 2024 Paves the Way for Next-Gen Technological Leadership in AI. |
Our most active stocks screener will show you the full list.
PFIZER INC
NYSE:PFE (4/29/2024, 7:19:45 PM)
After market: 25.69 +0.05 (+0.2%)25.64
+0.24 (+0.94%)
PFE News
8 hours ago - Pfizer Inc.FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
8 hours ago - Genmab A/STIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
14 hours ago - Zacks Investment ResearchHere's How to Play Pfizer (PFE) Stock Ahead of Q1 EarningsPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
17 hours ago - Zacks Investment ResearchWhy Pfizer (PFE) is a Top Value Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
18 hours ago - The Business JournalsPfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose
18 hours ago - The Motley Fool3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot PoleThese stocks aren't bargains.
20 hours ago - Pfizer Inc.Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
20 hours ago - InvestorPlace3 Dividend Stocks to Buy on the Dip: April 2024With the market presenting many vagaries, investors may take some solace in these dividend stocks to buy on the dip.
a day ago - The Business JournalsPfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dosePfizer's huge facility in Sanford produces its first FDA-approved gene therapy, which runs $3.5 million a dose.
2 days ago - The Motley FoolIs Viking Therapeutics Incredibly Undervalued?The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
2 days ago - The Motley Fool3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall StreetWhether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
3 days ago - The Motley Fool3 Dividend Stocks to Buy and Hold for the Next DecadeYou'll get dividends and more with these great stocks.
